Last reviewed · How we verify
NCT06117800
Effect of Evidence Based Teamwork System on Patient Safety Culture
NA trial testing TeamSTEPPS in Safety Issues in 135 participants. Completed in 20 August 2023.
18 July 2023
Quick facts
| Lead sponsor | Asmaa Elwan Mohammed Hassan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 135 |
| Start date | 1 April 2023 |
| Primary completion | 18 July 2023 |
| Estimated completion | 20 August 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- TeamSTEPPS
Conditions studied
- Safety Issues — all drugs for Safety Issues →
Sponsor
Asmaa Elwan Mohammed Hassan
Who can join
Adults 18 to 25, any sex, with Safety Issues. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of evidence-based teamwork system on patient safety culture among newly graduate nurses at Main Mansoura University Hospital
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluating the Effect of TeamSTEPPS on Teamwork Perceptions and Patient Safety Culture among Newly Graduated Nurses.
Hassan AE, Mohammed FA, Zakaria AM, Ibrahim IA. · · 2024 · cited 7× · PMID 38481268 · DOI 10.1186/s12912-024-01850-y
Verify or expand the search:
- PubMed search for NCT06117800
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of TeamSTEPPS
Trials testing the same drug.
- NCT04440228 — TeamSTEPPS in School Mental Health · NA · completed
Other recruiting trials for Safety Issues
Currently open trials in the same condition.
- NCT06485141 — BeSMART Secure Storage Counseling in the Inpatient Setting · NA · recruiting
- NCT06494527 — A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults · Phase 1 · active not recruiting
- NCT06189170 — Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients · EARLY_PHASE1 · recruiting
- NCT06509490 — NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors · NA · recruiting
- NCT06498167 — Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06117800 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asmaa Elwan Mohammed Hassan
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06117800.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing